Amneal Pharmaceuticals, Inc. Class A Common Stock

Go to Amneal Pharmaceuticals, Inc. Class A Common Stock Website

$8.00

0.17 (2.17%)
Live
Previous Close

$7.96

Day Range

$7.8 - $7.98

Previous Day Range

$7.665 - $7.84

Market Cap

$2.5 billion USD

Day Vol.

1.4 million

Previous Day Vol.

1.5 million

Currency

USD

Primary Exchange

New York Stock Exchange

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essentia...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Knight Therapeutics filed a New Drug Submission for CREXONT®, an innovative extended-release Parkinson's disease treatment, with Health Canada. The drug aims to improve patient treatment by offering longer drug absorption and fewer daily doses.

Related tickers: AMRX.

Read Full Article

Thérapeutique Knight has submitted a new drug submission for CREXONT®, a novel oral carbidopa/levodopa formulation for Parkinson's disease treatment, to Health Canada. The drug aims to provide improved therapeutic options with extended-release capsules and has demonstrated promising clinical trial results.

Related tickers: AMRX.

Read Full Article
Trending Tickers

Please sign in to view